4//SEC Filing
Sigal Charles Elliott 4
Accession 0001104659-23-077668
CIK 0001621227other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 5:02 PM ET
Size
5.6 KB
Accession
0001104659-23-077668
Insider Transaction Report
Form 4
Sigal Charles Elliott
Director
Transactions
- Award
Option to purchase Ordinary Shares
2023-07-03+933,317→ 933,317 totalExercise: $0.16From: 2024-07-03Exp: 2033-07-03→ Ordinary Shares (933,317 underlying)
Footnotes (1)
- [F1]The exercise price was converted from GBP0.12 based on an exchange rate of $U.S. 1.270841 to GBP1.00. The actual exercise price will be the pounds sterling amount.
Documents
Issuer
Adaptimmune Therapeutics PLC
CIK 0001621227
Entity typeother
Related Parties
1- filerCIK 0001661908
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 5:02 PM ET
- Size
- 5.6 KB